Happy New Year and welcome to 2022! Hopefully an uptrend in biotech will develop this year.
Covid is likely to remain a stubborn pest in one form or another for some time. Omicron won’t be the last variant that evades our defenses and puts lots of people in hospital. The focus must come onto improving treatments. Does Efti have a role here? We haven’t heard much from EAT Covid. But if it looks promising I’m sure BP wouldn’t wait, they would be quick to do a deal for further trials. The key factor is Efti is very safe. More to come here I think.
Overnight Market report, page-66
-
- There are more pages in this discussion • 2,766 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.045(13.2%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.0¢ | 29.5¢ | $1.468M | 4.740M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 37350 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 79295 | 3 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |